心血管领域综述的综述对关键方法学和透明性特征报告不足:基于PRIOR声明的的方法学研究
本研究评估心血管领域干预性综述的综述(overviews)的流行病学、报告特征及对PRIOR声明的依从性,共分析96篇综述。常见标题术语为「综述的综述」占40%,系统评价重叠处理方法报告仅25%,方案注册和完整资金披露各占45%,作者认为报告不足并建议采用PRIOR声明。
要点
- 共分析96篇心血管领域综述的综述,45%发表于2020至2022年,每篇中位包含15篇系统评价。
- 系统评价重叠处理方法报告率25%,原始研究重叠评估方法报告率19%,差异数据处理报告率11%。
- 方案注册和完整资金披露各占45%,数据共享声明占29%,作者认为报告不足。
核心结论
- 综述的综述在其特有方法学特征和多数透明性标志物方面报告不足。
- 研究界采用PRIOR声明可改善综述的综述的报告质量。
研究设计与样本
- 基于PRIOR声明的方法学研究,检索MEDLINE、Scopus和Cochrane系统评价数据库(2000年1月1日至2020年10月15日),并于MEDLINE、Epistemonikos和Google Scholar更新检索至2022年8月25日。
- 纳入以英文发表、主要涉及心血管领域人群、干预和结局的干预性综述的综述,由两名作者独立进行文献筛选、数据提取和PRIOR依从性评估,共分析96篇综述。
主要发现
- 96篇综述中43篇(45%)发表于2020至2022年,每篇中位包含15篇系统评价(四分位距9-28)。
- 最常见的标题术语为「综述的(系统)综述」,占38/96(40%)。
- 系统评价重叠处理方法报告于24/96(25%),原始研究重叠评估方法报告于18/96(19%),差异数据处理报告于11/96(11%),系统评价内原始研究方法学质量或偏倚风险评估方法报告于23/96(24%)。
- 数据共享声明见于28/96(29%),完整资金披露见于43/96(45%),方案注册见于43/96(45%),利益冲突声明见于82/96(85%)。
临床怎么用
- 作者认为,研究界采用PRIOR声明可改善综述的综述的报告质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to evaluate the epidemiology, reporting characteristics, and adherence to the Preferred Reporting Items for Overviews of Reviews (PRIOR) statement of overviews of reviews (overviews) of interventions in the cardiovascular field. STUDY DESIGN AND SETTING: MEDLINE, Scopus, and the Cochrane Database of Systematic Reviews were searched from January 1, 2000, to October 15, 2020. An updated search was performed in MEDLINE, Epistemonikos, and Google Scholar up to August 25, 2022. Overviews of interventions published in English and primarily considering populations, interventions, and outcomes pertinent to the cardiovascular field were eligible. Study selection, data extraction, and PRIOR adherence assessment were performed by two authors independently. RESULTS: We analyzed 96 overviews. Almost half (43/96 [45%]) were published between 2020 and 2022 and contained a median of 15 systematic reviews (SRs) (interquartile range, 9-28). The commonest title terminology was "overview of (systematic) reviews" (38/96 [40%]). Methods for handling SR overlap were reported in 24/96 (25%), methods for assessing primary study overlap in 18/96 (19%), handling of discrepant data in 11/96 (11%), and methods for methodological quality or risk of bias assessment of the primary studies within SRs in 23/96 (24%). Authors included data sharing statements in 28/96 (29%), complete funding disclosure in 43/96 (45%), protocol registration in 43/96 (45%), and conflict of interest statement in 82/96 (85%) overviews. CONCLUSION: Insufficient reporting was identified in methodological characteristics unique in overviews' conduct and most transparency markers. Adoption of PRIOR from the research community could ameliorate overviews' reporting.
引用
- Pamporis K, Bougioukas KI, Karakasis P, et al. Overviews of reviews in the cardiovascular field underreported critical methodological and transparency characteristics: a methodological study based on the Preferred Reporting Items for Overviews of Reviews (PRIOR) statement. J Clin Epidemiol. 2023. PMID: 37245702. doi:10.1016/j.jclinepi.2023.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。